IMO

1.9K posts

IMO banner
IMO

IMO

@mathonco

The Integrated Mathematical Oncology department uses the integration of theory & experiments to better understand cancer initiation, progression & treatment.

Moffitt Cancer Centre Katılım Ekim 2014
593 Takip Edilen2.4K Takipçiler
IMO retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Don’t miss Jill Gallaher, PhD (@jillagal), tomorrow at SMB #ECMTB2026, where she will share agent-based modeling research examining how tumor evolvability influences growth, treatment resistance and recurrence, with implications for designing evolution-informed treatment strategies. #MoffittECMTB2026 Learn more ➡️ bit.ly/3T8rFD3
Moffitt Cancer Center tweet media
English
0
5
11
617
IMO retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Tomorrow at SMB #ECMTB2026, Alexander Anderson, PhD (@ara_anderson), highlights how mathematical models, machine learning and digital twins can optimize evolution-informed cancer treatment strategies, including adaptive therapy, and help bridge the gap between preclinical research and clinical trials. #MoffittECMTB2026 Learn more: bit.ly/44q28Yy
Moffitt Cancer Center tweet media
English
0
3
7
590
IMO retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Don’t miss Renee Brady, PhD, tomorrow at SMB #ECMTB2026, where she will share research using mechanistic models of PSA dynamics to characterize patient-specific prostate cancer treatment response and disease progression, with the goal of informing more personalized treatment strategies. #MoffittECMTB2026 Learn more: bit.ly/4ycWre1
Moffitt Cancer Center tweet media
English
0
5
9
734
IMO retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Tomorrow at SMB #ECMTB2026 Diya Upadhyaya presents research combining mathematical modeling and patient-reported outcomes to forecast treatment response and disease progression in patients with non-small cell lung cancer, to support more personalized clinical decision-making. #MoffittECMTB2026 Learn more: bit.ly/4ydVdPK
Moffitt Cancer Center tweet media
English
0
4
6
683
IMO retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Catch Yunli Qi tomorrow at SMB #ECMTB2026, where he will present research combining deep reinforcement learning and spatial agent-based modeling to optimize adaptive therapy for prostate cancer, using historical treatment response to inform more robust treatment strategies. @OxUniMaths #MoffittECMTB2026 Learn more: bit.ly/4eWYKKY
Moffitt Cancer Center tweet media
English
0
1
5
512
IMO retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Don’t miss Franco Pradelli, PhD (@fpradelli94), tomorrow at SMB #ECMTB2026, where he will share research combining mathematical modeling and patient-derived cell lines to exploit evolutionary trade-offs in anaplastic large cell lymphoma and design treatment strategies that may prolong tumor control. #MoffittECMTB2026 learn more ➡️ bit.ly/4aL8IMQ
Moffitt Cancer Center tweet media
English
0
2
5
493
IMO retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Tomorrow at SMB #ECMTB2026, Daniel Camacho-Gomez, PhD, will share the latest research using machine learning and clinical imaging to predict skin lesion evolution, with the goal of supporting earlier, more personalized treatment decisions in skin cancer. #MoffittECMTB2026 learn more ➡️ bit.ly/4grSdcc
Moffitt Cancer Center tweet media
English
0
3
3
455
IMO retweetledi
Dr. Patrick Hwu
Dr. Patrick Hwu@PatrickHwuMD·
Live from #AACR26: I spoke with Sandy Anderson, PhD (@ara_anderson), about math oncology and how it’s helping us better predict cancer outcomes. By using data and machine learning, researchers can model how cancer may grow and respond to treatment, bringing us closer to more informed, personalized care. #AACR26 #MoffittAACR26 @MoffittNews
English
3
23
46
5K
IMO retweetledi
Sandy Anderson
Sandy Anderson@ara_anderson·
Ok I know at this point it might be a waste of time but I'm determined to finish posting about #MathOnco25! We were about half way through day 3 but before I go on there it wasn't all work - we also had lots of fun!
Sandy Anderson tweet mediaSandy Anderson tweet mediaSandy Anderson tweet mediaSandy Anderson tweet media
English
1
1
7
404
IMO retweetledi
Sandy Anderson
Sandy Anderson@ara_anderson·
Next is #AndersonLab member M A Masud @masud_math: "Developing model-based pipeline for combination therapy cycling: KRAS mutated NSCLC". Unfortunately the recording didn't work for Masuds presentation but expect a preprint on this work shortly @mathonco #MathOnco25 @MoffittNews
Sandy Anderson tweet mediaSandy Anderson tweet mediaSandy Anderson tweet media
English
0
2
7
421
IMO retweetledi
Jeffrey West
Jeffrey West@mathoncbro·
In 2026, please consider following the journey of math oncology research by subscribing to our newsletter (7yrs, 350 issues, 2500 subs): mathematical-oncology.org/newsletter Tomorrow's newsletter is a recap of 2025, and links to papers on fitness landscapes, cancer evolution, virtual trials, and more...
Jeffrey West tweet media
English
0
3
9
999
IMO retweetledi
Jeffrey West
Jeffrey West@mathoncbro·
This book chapter outlines possible ideas for "Evolution-based treatment protocols". Ch 38, in "Cancer Systems Biology: Translational Mathematical Oncology" academic.oup.com/book/61412
Jeffrey West tweet media
English
1
8
34
3.5K
IMO
IMO@mathonco·
Only a few more days before the deadline: December 1st! Unique fully-funded PhD program in #MathOnco (and other disciplines) in an National Cancer Institute (@theNCI) designated cancer center
Moffitt Cancer Center@MoffittNews

Advance your career in #CancerResearch with the Moffitt Cancer PhD program! Application deadline: December 1, 2025 Are you passionate about fighting cancer? Our program prepares future scientists with a rigorous curriculum and offers four unique majors: • Cancer Biology • Cancer Chemical Biology • Cancer Immunology & Immunotherapy • Integrated Mathematical Oncology Why Moffitt? • Access to top research facilities • Collaborate with world-leading scientists • Hands-on experience in cutting-edge research • Supportive environment for innovation • Unmatched translational environment, turning discoveries into cures Start your journey to make a difference in cancer care and innovation. Learn more and apply now: bit.ly/3YH7yfH

English
0
0
0
254